4/A: CareDx Director Hannah Valantine Amends Form 4 Filing to Correct Stock Option Exercise Price
SEC Filing (Form 4/A)
Hannah Valantine, a director of CareDx, Inc., filed an amendment to a Form 4, correcting the exercise price of a stock option.
Summary
- Hannah Valantine, a director at CareDx, Inc., filed an amended Form 4 with the SEC.
- The amendment corrects the exercise price of a stock option previously reported.
- The original filing was made on June 18, 2024, and the corrected transaction date is June 14, 2024.
- The stock option grants Valantine the right to buy 16,048 shares of CareDx common stock at an exercise price of $14.19.
- The options vest monthly, starting July 14, 2024, and continuing through June 14, 2025, with 1/12th of the shares vesting each month.
- The options expire on June 14, 2034.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for company insiders, providing transparency into their transactions in the company's securities. Amendments are common and can be due to various reasons, including correcting errors in the original filing.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of the stock option transaction. |
| 06/18/2024 | Date of original Form 4 filing. |
| 06/20/2024 | Date of amended Form 4/A filing. |
| 07/14/2024 | First vesting date for the stock options. |
| 06/14/2025 | Final vesting date for the stock options. |
| 06/14/2034 | Expiration date for the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.